Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Coherus Oncology, Inc.
Coherus Oncology, Inc.
BioNTech SE
Centre Oscar Lambret
AbbVie
University Hospital, Clermont-Ferrand
Institut du Cancer de Montpellier - Val d'Aurelle
Psyence Australia Pty Ltd
Boston Scientific Corporation
University of California, San Diego
Sun Yat-sen University
HealthPartners Institute
Centre Leon Berard
Brigham and Women's Hospital
TaiRx, Inc.
UNICANCER
Bayer
Astellas Pharma Inc
Leap Therapeutics, Inc.
Institut Bergonié
BioMed Valley Discoveries, Inc
Jazz Pharmaceuticals
NuCana plc
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
AbbVie
University of California, San Diego
Azienda USL Reggio Emilia - IRCCS
Peking University People's Hospital
PhytoHealth Corporation
Pfizer
Blokhin's Russian Cancer Research Center
Suzhou Teligene Ltd.
Thomas Jefferson University
Janssen Research & Development, LLC
BPGbio
Lukas Biomedical Inc.
UNICANCER
Trishula Therapeutics, Inc.
Actuate Therapeutics Inc.
University of California, San Diego
Al-Azhar University
AstraZeneca
Novartis
Servier
Genentech, Inc.
Federation Francophone de Cancerologie Digestive
Federation Francophone de Cancerologie Digestive
Exelixis
Jules Bordet Institute
N.N. Petrov National Medical Research Center of Oncology